Literature DB >> 22710883

Systemic thrombolysis for acute, severe Budd-Chiari syndrome.

Paul J Clark1, Richard E Slaughter, Dorothy J Radford.   

Abstract

Budd-Chiari syndrome (BCS) or hepatic venous outflow obstruction, is a rare and complex clinical entity, with diverse aetiology and a wide range of presentations. Its rarity and heterogeneity create significant challenges for evidence-based clinical decision-making, particularly in the even more infrequent setting of acute BCS presentation. Here we present the case of a young woman with acute, severe BCS, where treatment alternatives were limited due to a significant IVC thrombus burden. A clearly defined acute onset allowed the prompt use of systemic thrombolysis, conducted in consultation with a multi-disciplinary team of clinicians, with close monitoring for both treatment response and complications. Her treatment resulted in resolution of hepatic vein occlusion and prevention of the potentially significant clinical sequelae. We review the literature and discuss current opinion in the management of BCS.

Entities:  

Mesh:

Year:  2012        PMID: 22710883     DOI: 10.1007/s11239-012-0760-4

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   5.221


  44 in total

1.  Budd-Chiari syndrome resulting from intrahepatic IVC compression secondary to blunt hepatic trauma.

Authors:  D J Markert; K Shanmuganathan; S E Mirvis; Y Nakajima; M Hayakawa
Journal:  Clin Radiol       Date:  1997-05       Impact factor: 2.350

2.  Budd-Chiari syndrome after oral contraceptives.

Authors:  I Krass
Journal:  Br Med J       Date:  1968-03-16

3.  Risk of hepatic vein thrombosis in relation to recent use of oral contraceptives. A case-control study.

Authors:  D Valla; M G Le; T Poynard; N Zucman; B Rueff; J P Benhamou
Journal:  Gastroenterology       Date:  1986-04       Impact factor: 22.682

4.  Budd-Chiari syndrome: a common complication of Behçet's disease.

Authors:  Y Bayraktar; F Balkanci; M Bayraktar; M Calguneri
Journal:  Am J Gastroenterol       Date:  1997-05       Impact factor: 10.864

5.  Budd-Chiari syndrome caused by a web in the inferior vena cava.

Authors:  F Schaffner; H L Gadboys; A P Safran; M G Baron; A H Aufses
Journal:  Am J Med       Date:  1967-05       Impact factor: 4.965

Review 6.  Surgical treatment of renal cell carcinoma associated with Budd-Chiari syndrome: report of four cases and review of the literature.

Authors:  H Kume; S Kameyama; Y Kasuya; A Tajima; K Kawabe
Journal:  Eur J Surg Oncol       Date:  1999-02       Impact factor: 4.424

7.  Budd-Chiari syndrome in a patient with the lupus anticoagulant.

Authors:  C Pomeroy; R G Knodell; W R Swaim; P Arneson; M L Mahowald
Journal:  Gastroenterology       Date:  1984-01       Impact factor: 22.682

Review 8.  Pharmacological thrombolysis in Budd Chiari syndrome: a single centre experience and review of the literature.

Authors:  S Sharma; A Texeira; P Texeira; E Elias; J Wilde; S P Olliff
Journal:  J Hepatol       Date:  2004-01       Impact factor: 25.083

9.  Budd-Chiari syndrome following pregnancy. Report of 16 cases, with roentgenologic, hemodynamic and histologic studies of the hepatic outflow tract.

Authors:  M S Khuroo; D V Datta
Journal:  Am J Med       Date:  1980-01       Impact factor: 4.965

10.  Tissue plasminogen activator for hepatic vein thrombosis in paroxysmal nocturnal haemoglobinuria.

Authors:  M F McMullin; P Hillmen; J Jackson; P Ganly; L Luzzatto
Journal:  J Intern Med       Date:  1994-01       Impact factor: 8.989

View more
  2 in total

Review 1.  An Update on the Management of Budd-Chiari Syndrome.

Authors:  A Sharma; S N Keshava; A Eapen; E Elias; C E Eapen
Journal:  Dig Dis Sci       Date:  2020-07-20       Impact factor: 3.199

2.  Catheter-directed thrombolytic therapy combined with angioplasty for hepatic vein obstruction in Budd-Chiari syndrome complicated by thrombosis.

Authors:  Qingqiao Zhang; Hao Xu; Maoheng Zu; Yuming Gu; Ning Wei; Wenliang Wang; Zhikang Gao; Bin Shen
Journal:  Exp Ther Med       Date:  2013-07-30       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.